Position in ACET
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,298,959
+$298,661 QoQ
Shares Held
844,787
-17.8% QoQ
Ownership
9.02%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#2
of 56 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACET Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. ACET ranks #63 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $630,516,329 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
6,776,632 | $343,914,074 | |
| 3 | MBX |
MBX Biosciences, Inc.
|
3,428,736 | $189,266,227 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
2,209,400 | $118,578,498 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
2,555,877 | $112,433,029 | |
| 6 | CRVS |
Corvus Pharmaceuticals, Inc.
|
7,165,006 | $107,045,189 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
3,027,328 | $105,169,374 | |
| 8 | ARGX |
Argenx SE
|
92,880 | $86,171,277 |
All Filings in ACET
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,298,959 | 844,787 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,000,298 | 1,027,944 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,655,288 | 1,027,944 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,272,183 | 11,447,140 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,982,755 | 11,447,140 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,642,590 | 11,447,140 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,012,148 | 11,447,140 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,483,881 | 11,447,140 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,851,039 | 11,447,140 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $26,900,779 | 11,447,140 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $15,728,844 | 8,322,140 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,401,331 | 8,322,140 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $20,222,800 | 8,322,140 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $42,895,526 | 7,447,140 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $66,577,431 | 7,447,140 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $105,898,330 | 7,447,140 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $108,728,258 | 7,447,141 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $148,719,405 | 7,447,141 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $130,250,496 | 7,447,141 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $56,705,591 | 7,232,856 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $74,426,088 | 7,232,856 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $94,605,756 | 7,232,856 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $94,254,523 | 6,708,507 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $79,764,148 | 6,708,507 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||